Differences in early versus late extracavitary arterial graft infections  by Calligaro, Keith D. et al.
Differences in early versus 
ùarterial graft infections 
late extracavitary 
Keith D. Calligaro, MD, Frank J. Veith, MD, Michael L. Schwartz, MD, 
Matthew J. Dougherty,  MD, and Dominic A. DeLaurentis, MD, 
Philadelphia, Pa., and New York, N.Y. 
Purpose: The purpose of this report was to determine differences in presentation, 
bacteriology, management, and outcome of early (EGIs) versus late extracavitary arterial 
graft infections (LGIs). 
3/Iethods: Between July 1, 1979, and June 30, 1994, we treated 141 patients with infected 
extracavitary arterial grafts (112 prosthetic, 29 vein) with selective partial or complete 
graft preservation. 
Results: A total of 99 (70%) EGIs ( < 2 months) and 42 (30%) LGIs (4 to 96 months) were 
involved. The hospital mortality rate was 14% (20 of 141), and the amputation rate in 
survivors was 13% (16 of 121). No significant difference in mortality (16% [16 of 99] vs 
10% (4 of 42]) or limb loss (16% [13 of 83] vs 8% [3 of 38]) was seen between EGIs and 
LGIs, respectively (p > 0.05). Patients with EGIs were as likely to have a disrupted 
anastomosis (17% [17 of 99] vs 21% [9 of 42]) or systemic sepsis (4% [4 of 99] vs 4% 
[2 of 42]) as patients with LGIs, respectively (p > 0.05). Patients with EGIs were more 
likely to have patent, intact grafts and to be treated by complete graft preservation (61% 
[61 of 99] vs 26% [11 of 42]) (p = 0.0001). In comparison, patients with LGIs were more 
likely to have occluded grafts and to require subtotal graft excision (48% [20 of 42] vs 18% 
[18 of 99]) (p = 0.0001). Surviving patients with EGIs treated by complete graft 
preservation were more likely to have successful healing of their wounds after long-term 
follow-up (average 3 years) than patients with LGIs (79% [41 of 52] vs 40% [4 of 10], 
respectively) (p = 0.03). The pathogens cultured from wounds ofEGIs versus LGIs were 
pure gram-positive bacteria in 49 (49%) versus 19 (46%), pure gram-negatives in 18 
(18%) versus 11 (26%), and both types in 33 (33%) versus 12 (28%) (p > 0.05). 
Conclusion: Complete graft preservation can be attempted more frequently and is more 
likely to be successfial in EGIs than in LGIs. No difference in bacteriology was seen 
between the two groups. Graft-preserving treatment can be successfial but should only be 
cautiously attempted in patients with late extracavitary arterial graft infections. (J VASC 
SURG 1995;22:680-8.) 
Management of infected arterial grafts remains 
controversial. Although many anthorities continue to 
recommend total graft excision for all infected arterial 
grafrs, 1-4 selective graft preservation of infected ex- 
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tracavital T grafts under well-defined circumstances 
may represent an improved method of treating these 
complications, s-7To bet-ter define the characteristics 
of early and late graft infections and to further 
identify factors that would help predict successful 
complete graft preservation, we compared the pre- 
sentation, bacteriology, management, and outcome 
of early (EGIs) versus late extracavitary graft in- 
fections (LGIs). To our knowledge an in-depth 
analysis of these factors as they relate to the time 
of onset of arterial graft infections has not been 
done. 
PAT IENTS AND METHODS 
Between July 1, 1979, and June 30, 1994, we 
treatcd 141 consecutive patients with infected extra- 
cavitary arterial grafts with selective partial or com- 
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Table I. Type of infected bypass (141 cases) 
Prosthetic Vein Total 
Femoropopliteal 45 10 55 
Femorotibial 28 11 39 
Aortofemoral (confined to groin) 14 0 14 
Femorofemoral crossover 11 0 11 
Popliteal-tibial, popliteal-pedal 0 8 8 
Common femoral artery interposition 8 0 8 
Axillofemoral 6 O 6 
Total 112 29 141 
plete graft preservation at Pennsylvania Hospital in 
Philadelphia (51 cases) and at Montefiore Medical 
Center in New York (90 cases). A total of 112 
infected prosthetic grafts (19 Dacron, 93 polytet- 
rafluoroethylene) and 29 infected autologous vein 
grafts (Table I) were involved. The infection directly 
involved an anastomosis in 123 cases and was 
confined to the body of the graft in 18 cases (Table 
II). The graft was exposed in all cases before or after 
operative wound debridement was performed. 
Follow-up ranged between 1 month and 15 years 
(average 3 years). Patients with infection involving 
the intraabdominal portion of an aortic graft were 
not considered in this review. 
Time of onset of graft infection was defined as the 
appearance of clinical signs that suggested the pres- 
ence of an infectious process that ultimately proved to 
involve the underlying arterial graft, such as wound 
erythema or drainage, a pulsatile mass, frank hemor- 
rhage, or systemic sepsis. Early graft infections were 
arbitrarily defined as those occurring within 2 
months of operation because no graft infections 
were seen between 2 and 4 months after operation 
(Table Ili). Cultures were positive for bacteria and 
were obtained from fluid or pus ~ direct contact with 
the graft in all cases. 
Total graft excision was performed when an 
infected graft caused systemic sepsis. This clinical 
finding implied that the graft was irreversibly seeded 
with bacteria and necessitated complete removal. 
Subtotal graft excision was performed when patients 
had either a disrupted anastomosis or an occluded 
graft. When patients had an infected anastomotic 
pseudoaneurysm or frank hemorrhage, excision of 
the infected portion of the graft was carried out. 
The remaining portion of the graft was often used 
as an inflow or outflow conduit if clinical, radio- 
logic, and operative findings ruled out infection in 
that part of the graft. When patients had an infected 
occluded graft and intact anastomoses, subtotal 
excision of the graft was performed leaving an 
oversewn patch of the original graft on the un- 
derlying artery. In this manner the anastomosis did 
not need to be taken down, a new autologous tissue 
patch did not need to be placed to prevent arterial 
stenosis, and the need for a new bypass was often 
avoided. When patients did not have systemic sepsis 
and had infection confined to a segment of a patent 
graft with intact anastomoses, complete graft pres- 
ervation was attempted. Placement of a muscle flap 
has been increasingly used to salvage exposed 
grafts, 8,9 but we have shown that healing via delayed 
secondary intention wound closure can frequently 
be successful. 5'6 We were particularly anxious to 
cover an exposed vein graft with autologous tissue 
such as a muscle flap or sldn graft because these 
grafts were particularly prone to rupture or become 
dessicated and undergo thrombosis if wound heal- 
ing was attempted by granulation tissue formation 
alone.l° 
Regardless of the manner of presentation, in- 
fected wounds were repeatedly and aggressively 
debrided in the operating room. All infected or 
necrotic tissue was excised along with any exudate on 
the exposed graft. Wet-to-dry dressing changes were 
performed three times a day with a dilute povidone- 
iodine solution, and appropriate intravenous antibi- 
otics were administered for at least 6 weeks, ll When 
graft excision proved necessary, our preferred 
method of revascularization was tunneling a new 
graft through uninfected routes as opposed to placing 
an autologous graft in the infected wound, e Not all 
patients with subtotal or total graft excision under- 
went arterial reconstruction. All patients with patent 
outflow arteries and threatened lower extremities 
after graft excision underwent emergent or urgent 
revascularization if their medical status permitted 
another major operation. However, several patients 
who had subtotal or total graft excision did not have 
limb-threatening ischemia after graft excision be- 
cause of the presence of collateral flow and did not 
undergo revascularization. Several patients with criti- 
cal ischemia after graft excision had unreconstruc- 
table distal arterial disease and therefore were not 
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Table II. Location of graft infection 
(141 cases) 
Anastomotic (123) 
Common femoral artery 89 
Tibial 20 
Popliteal 13 
Axillary 1 
Confined to body of graft (18) 
Thigh 9 
Calf 3 
Ankle 2 
Flank 2 
Chest 1 
Knee 1 
candidates for revascularization a d required major 
amputations. 
Differences between outcomes were evaluated 
with a one-tailed t test withp value < 0.05 considered 
a statistically significant difference. 
RESULTS 
Ninety-nine (70%) patients had EGIs (-<2 
months), and 42 (30%) had LGIs (4 to 96 months). 
Approximately one quarter of the patients in each 
group were referred to out medical centers with graft 
infections. All patients had purulent drainage from 
the wound except a few patients who had a pulsatile 
mass and intact incisions with underlying infected 
pseudoaneurysms. 
Patients with EGIs were as likely to have a dis- 
rupted anastomosis (17% [17 of 99] vs 21% [9 of 
42]) or systemic sepsis (4% [4 of 99] vs 4% [2 of 42]) 
as were patients with LGIs (p > 0.05). All patients 
who had dismpted anastomoses had patent grafts. 
Patients with EGIs were more likely to have patent 
intact grafts and to be treated by complete graft pres- 
ervafion than were patients with LGIs (61% [61 of 
99] vs 26% [11 of 42], respectively) (p = 0.0001). 
In comparison, patients with LGIs were more likely 
to have occluded grafts and require subtotal graft 
excision than were patients with EGIs (48% [20 of 
42] vs 18% [18 of 99], respectively) (4o = 0.0001). 
The overall hospital mortality rate was 14% (20 
of 141). No significant difference in mortality (16% 
[16 of 99] vs 10% [4 of 42] (p > 0.05) was seen 
between EGIs and LGIs, respectively. Causes of 
death in patients with EGIs were cardiac-related in six 
cases (four managed by complete graft preservation 
for patent grafts with intact anastomoses, one man- 
aged by subtotal graft excision for an occluded graft, 
and one managed by total graft excision for Nee& 
ing), persistent sepsis in spite of evenmal total graft 
excision in six cases (three managed initially by 
Table III. Onset of graft infection 
Months ince surgery No. of grafl infections 
0-1 90 
i-2 9 
2-3 0 
3-4 6 
4-5 5 
5-6 7 
6-7 1 
7-8 1 
8-9 0 
9-10 3 
10-11 2 
11-12 5 
12-13 1 
13-14 2 
14-15 0 
15-16 0 
I6-17 2 
17-18 1 
20-21 1 
23-24 1 
32-33 1 
44-45 1 
47-48 1 
95-96 1 
complete graft preservation and three by immediate 
total graft excision for bleeding and sepsis), and 
hemorrhage in four cases (two managed initially by 
complete graft preservation and two by total graft 
excision for bleeding). Deaths in patients with LGIs 
were due to persistent sepsis in three cases (two 
managed initially by total graft excision for bleeding 
and one by complete graft preservation) and myo- 
cardial infarction in one case managed initially by 
subtotal graft excision for an occluded graft. The 
survival rate in all patients treated by complete graft 
preservation was similar (86%, 62 of 72) to that of 
patients treated by subtotal or total graft excision 
(86%, 59 of 69). 
The overall amputation rate in survivors was 13% 
(16 of 121). No significant difference in limb loss was 
seen between EGIs and LGIs (16% [13 of 83] vs 8% 
[3 of 38], respectively) (p > 0.05). Surviving pa- 
tients in both groups who had occluded grafts, 
systemic sepsis, or graft hemorrhage and therefore 
required subtotal or total graft excision tended to 
have higher amputation rates (19% [11 of 59]) than 
did patients who had intact patent grafts and were 
treated by complete graft preservation (8% [5 of 62]) 
(p > 0.05). 
Surviving patients with EGIs treated by complete 
graft preservation were almost wice as likely to have 
successful healing of their wounds involving the 
underlying infected graft and with the graft remain- 
ing intact after long-term follow-up (average 3 years) 
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than were patients with LGIs (79% [41 of 52] vs 
40% [4 of 10]) (2 = 0.03). Wound healing in 
patients treated by complete graft preservation was 
considered tmsuccessful ifthe wotmds did not heal or 
developed recurrent infection or bleeding at any time 
during hospitalization or long-term follow-up. 
No significant differences in successful outcome 
were seen in surviving patients treated by attempted 
complete graft preservation when the following 
factors were analyzed: anastomotic (70% [35 of 50]) 
vs body ofgraft (83% [10 of 12]) infections, ó grafts 
exposed at the time ofpresentation (70% [28 of 40]) 
vs grafts exposed only after operative debridement 
(77% [17 of 22]), prosthetic 70% [30 of 43]) vs rein 
(79% [15 of 19]) graft infections, 1°and infections 
treated by delayed secondary intention wound heal- 
ing (71% [34 of 48]) vs those treated with muscle 
flaps (79% [11 of 14]) 8 (2 > 0.05 for all variables). 
No significant differences were seen in the type of 
bacteria cansing early or late graft infections. Pure 
gram-positive bacterial cultures were obtained from 
42 (49%) EGI wounds compared with 25 (46%) 
LGI wounds, pure gram-negatives from 15 (18%) 
versus 14 (26%) wounds, and both types from 28 
(33%) versus 15 (28%) wotmds (2 > 0.05) (Table 
IV). Pseudomonas eruginosa was somewhat more 
commonly culmred from LGIs than from EGIs (26% 
[11 of 42] vs 16% [16 of 99], respectively) (2 > 
0.05). Also, no significant differences were seen 
between successful outcome in surviving patients 
treated by attempted complete graft preservation  
the basis of class of bacteria: gram-positive bacteria 
only, 77% (23 of 30), gram-negative bacteria only, 
77% (10 of 13), and mixed cultures, 63% (12 of 19). 
However, it should be noted that Pseudomonas was 
associated with a greater likelihood of having sepsis 
or hemorrhage and dying of graft infection than 
other types of bacteria} 2 
DISCUSSION 
In our series most (70%) extracavitary arterial 
graft infections were seen within 2 months after the 
most recent arterial operation. The most delayed 
infection was seen 8 years after graf* implantation was 
performed, and the average time of graft infection 
presentation was 3 years after the last arterial 
operation was performed. The factors accounting for 
such varying onsets of graft infection are not clearly 
known. Most anthorities believe that most arterial 
graft infections are due to bacteria that are introduced 
into the wound at the time of operation. 13a4 How- 
ever, the infection may not become clinically evident 
until the patient becomes immunocompromised or 
other factors predispose to bacterial proliferation i  
the wound.lS It has been weil established that patients 
become relatively anergic after major trauma or 
operation with impaired neutrophil delivery and 
macrophage function and that these and other 
stressful events may predispose to sudden bacterial 
proliferation} ~,16 Host defenses may also be impaired 
to some degree when a foreign material such as a 
prosthetic arterial graft is implanted. The presence of 
a foreign material may deplete complement and 
subsequently impair lysis of gram-negative bacteria.17 
Bandyk et al. 13 have demonstrated that indolent 
bacteria such as Staphylococcus epid¢rmidis introduced 
at the time of operation can cause delayed infection 
years later because of the presence ofa slime layer that 
permits adherence to the graft and may enhance 
bacterial survival. 
Other factors predisposing tolate graft infections 
include hematogenous spread of bacteria nd seeding 
from organisms present in intraluminal thrombus or 
the native artery at the time ofgraft implantation.14-19 
Moore 14 has demonstrated that bacteremia c used by 
gastrointestinal, genitourinary, or dental manipula- 
tion can result in seeding of the graft. Twenty percent 
of native arteries at the time of graft implantation 
may ultimately culture bacteria} 8 If the artery wall 
was culture-positive, the chance of subsequent pros- 
thetic graft infection was increased to approximately 
10%. 18 Ernst 19 has also demonstrated that thrombus 
lining aortic aneurysms will culture bacteria in 
approximately 10% of patients. Although these 
retrospective studies do not settle the issue, we 
believe that graft contamination at the time of 
implantation is probably the more common cause. 
Another unresolved issue regarding onset of 
arterial graft infections i whether EGIs seen less than 
2 months after graft placement represent true graft 
infections or simply wound-healing problems with 
an infectious component, even though all of our 
EGIs had culture-positive purulent material in con- 
tact with the graft. Nevertheless most of these early 
infections are first seen in a benign fashion and 
therefore might be expected to be managed success- 
fully with less aggressive measures. In support of this 
concept, complete graft preservation in our series was 
significantly more likely to be attempted and success- 
fully accomplished with EGIs compared with LGIs in 
our series. In both groups this management was 
attempted only when criteria for complete graft 
preservation existed, that is, the graft was patent, the 
anastomoses were intact, and the patient did not have 
sepsis. We speculate that arterial grafts that develop 
clinical signs of infection more than 2 months after 
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Table IV. Bacteriologic condition of early (EGI) and late (LGI) graft infections 
EGI (99) LGI (42) 
Gram-positive bacteria 
Pure 49 (49%) 19 (46%) 
Staphylococcus aureus 35 20 
Staphylococcus epidermidis 19 16 
Streptococcus faecalis 21 5 
Streptococcus viridians 6 2 
Streptococcus Group D non-enterococcus 2 2 
Diphtheroides 3 2 
Corynebacteria 3 1 
Clostridia 1 0 
Gram-negative bacteria 
Pure 18 (18%) 11 (26%) 
Pseudomonas eruginosa 16 11 
Proteus 10 4 
Eschericheria coli 10 2 
Bacteroides fragilis 5 2 
Morganella morgagni 4 1 
Serratia marsescans 2 4 
Enterobacter 2 2 
Acinetobacter 2 1 
Salmonella 1 0 
Klebsiella 1 1 
Citrobacter 1 0 
Achrobacter 0 1 
Mixed 33 (33%) 12 (28%) 
implantation may be more likely to become impreg- 
nated with bacteria nd therefore would not respond 
to graft-preserving methods in spite of aggressive 
operative debridement of the surrounding infected 
soft tissue and prolonged administration f intrave- 
nous antibiofics. 
However, evidence refuting the notion that EGIs 
represent soft-tissue infections without rue involvc- 
ment of the underlying graft includes out finding that 
EGIs were as likely to be seen with virulent mani- 
festations of infection, namely graft hemorrhage or
systemic sepsis, as LGIs. We believe that time of 
onset of infection is likely to be a dominant factor 
influencing outcome of graft preservation. As men- 
tioned previously, all grafts were exposed and directly 
involved with the infectious process. Additionally, 
mortality rates were similar in spite of identical 
strategies for both groups. These findings tend to 
contradict suggestions that complete graft preserva- 
tion may be more successful in patients with EGIs 
simply because these infections represented periop- 
erative wound-healing complications rather than 
"true" graft infections. 
Patients with LGIs were more likely to have 
occluded grafts and therefore to require mandatory 
partial graft excision than were pafients with EGIs. 
When infection involves an occluded graft, we 
speculate that bacteria proliferate in the luminal 
thrombus and that irreversible seeding of the graft 
may result. Therefore the primary reason complete 
graft preservation was attempted more often with 
EGIs than with LGIs may have been because arly 
infections were more likely to have patent grafts and 
not because of differences inhemorrhage orsystemic 
sepsis as the presenting symptom. 
Differences in presentation and treatment out- 
come for early and late graft infections could not be 
dearly related to bacteriologic differences. The inci- 
dence of pure gram-positive, pure gram-negative, or 
mixed bacteria was not significantly different be- 
tween EGIs and LGIs. However, Pseudomonas erugi- 
nosa was more commonly cultured from LGIs than 
from EGIs. Pseudomonas represents one of the most 
virulent organisms responsible for arterial graft 
infections, and we have suggested that he presence of 
this bacteria is a relative contraindication for at- 
tempted complete graft preservation. 12,2° Further 
follow-up of larger numbers of graft infections 
analyzing the prevalence of Pseudomonas will be 
necessary before conclusions can be reached that this 
organism isresponsible for the lower successful graft 
preservation rate in LGIs. 
This study suggests that most patients with an 
infected cxtracavitary prosthetic or autologous vein 
graft within 2 months of implantation will have a 
successful outcome when selective complete graft 
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preservation is attempted under appropriate circum- 
stances with the strategy we have outlined. However,  
we must emphasize that only approximately half o f  all 
patients with infected extracavitary arterial grafts are 
candidates for attempted complete graft preserva- 
tion. Therefore our current recommendations for at- 
tempted  complete preservation of  infected extracavi- 
tary arterial grafts include (1) patency of  the graft, (2) 
intact anastomoses, (3) absence of  systemic sepsis, 
(4) absence o f  Pseudomonas as a causative organism, 
and (5) onset o f  graft infection within 2 months o f  
operat ion.  Complete graft preservation may be suc- 
cessful in selected patients with graft infections seen 
more than 2 months after graft implantation if the 
first four criteria are fulfilled, but this form of  treat- 
ment should be attempted only in patients in whom a 
secondary revascularization procedure is not possible 
and to avoid a major amputation i fthe graft is totally 
excised. 
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DISCUSSION 
Dr. Padberg (East Orange, N.J.). The experience just 
described brings together a1arge, 15-year experience from 
two respected institutions. The authors managed 141 
extracavitary graft infections and chssified them as early, if 
they occurred within 2 months of operation, and hte, if 
they appeared after this time. The simihrity between 
mortality, limb loss, microbiology, and morbidity between 
the t-wo groups is interesting but does not mandate 
different operative approaches. 
However, 20 cases (a 14% mortality rate) breaks down 
into seven from cardiac, nine from sepsis, and four from 
bleeding, which may presumably be related to the treat- 
ment for the graft infection. Ten of these had total or 
subtotal excision at their initial therapy; the remaining ten 
were initially treated with an attempt at complete graft 
preservation. This observation forces the question-would 
initial complete excision have improved this outcome? 
What is the frequency of bleeding from an anastomosis 
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when exposed during treatment for preservation; what 
is the incidence of bleeding for the exposed vein 
graft during treatment? Does this source of death di- 
minish during the 15-year experience that you have de- 
veloped? 
In the manuscript, he authors peculate that early graft 
infection represents a consequence of local wound prob- 
lems. Supporting this hypothesis the frequency of groin 
site involvement and the response to local wound care. 
Indeed, the disappearance ofmonofilament suture beneath 
a bed of granulating tissue is a clinical relief. I would concur 
with this hypothesis and ask the authors whether anasto- 
motic hemorrhage orpersistent sepsis was marked by more 
virulent organisms? 
The distribution of microorganisms was typical with a 
predominance of Staphylococcus aureus, coagulase-negative 
staphylococcus, P eudomonas, and Proteus. Cultures were 
"Obtained from fluid or pus in direct contact with the graft 
in all cases." Were there any grafts in which the infection 
was suspected but they were not included because you did 
not get a positive culture? 
Subtotal graft excision presumes that the residual pros- 
thetic material is uninfected. We assessed the incorporation 
status of these graft segments in relationship to enhanced 
microbiologic culture techniques at 2 weeks and 3 months, 
which was presented to this organization i 1993 and ap- 
peared in the February Archives of Surgery. This clinical 
finding, the status of incorporation, had an accuracy of 
91%. An incorporated graft had a 96% specificity, reassur- 
ing the surgeon of the absence of infection. Conversely, the 
disincorporated graft had a 70% sensitivity. The 3-month 
results were only slightly improved. Were cultures of the 
residual graft fragments taken during subtotal graft inci- 
sion? If so, what were the results, and how did they affect 
management? Specifically, would a positive culture for 
Pseudomonas from the residual graft fragment after subto- 
tal graft removal suffice as an indication for reexploration 
and reexcision of the remaining raft? 
The authors counsel us to use caution when attempting 
to treat late graft infections, recommending that this be 
attempted only in those with patent, intact anastomoses, 
patients who are not systemically septic, are not infected 
with Pseudomonas, and do not have available secondary 
revascularization ptions. Could they speculate as to why 
this small but important group did so poorly in comparison 
with the early graft infections? Were these late grafts 
possibly infected after amputations? 
Dr. Matthew J. Dougherty (Philadelphia, Pa.). The 
total mortality figures are not significantly different from 
other published reports and are actually better than most. 
When we specifically looked to see whether it was the 
attempts at preserving all or part of the graft that was 
responsible for some of these episodes of persistent sepsis 
or hemorrhage causing mortality, the answer eally is no. 
Most of the patients who died of sepsis or hemorrhage were 
actually initially treated with complete graft excision. 
What can one do to make fatal hemorrhage l ss likely 
after attempting graft preservation? We keep these patients 
in the intensive care unit under close observation until their 
wounds are either covered with a muscle flap or completely 
granulated. 
The second question regards exposure of vein anasto- 
moses. We have learned that exposed vein grafts tend to get 
desiccated and can rupture, and this is the group for which 
we favor muscle flaps. 
It is hard to say whether our mortality rate has 
decreased over this 15-year period, but certainly we feel we 
have refined our selection criteria, and hopefully this will 
translate to lower overall mortality. 
The third question asks whether culture-negative 
patients were included. No, in fact, we did not include 
patients who had negative cultures; admittedly certain 
Staphylococcus epidermidis infections may have been missed. 
A lot of these infections were early, and it has been 
suggested that maybe these really are not true graft 
infections, that maybe they are just "wound problems" 
early after operation. So to specifically avoid that bias, we 
required all these patients to have positive cultures from 
fluid around the graft. 
The fourth question relates to specific organisms; as 
alluded to, certain organisms have been shown to confound 
attempts at graft preservation, and Pseudomonas aeruginosa 
is specifically a bad actor for this. Some of these failures 
with Pseudomonas organisms did have hemorrhagic or 
septic mortality. If we had done a subtotal excision and then 
found that the Pseudomonas organism is what cultured out, 
would we go back and remove the remaining portion of the 
graft? I think the answer to that is still probably no. We do 
not have a large number of patients who would fit that 
description. Our main caution against he graft-preserving 
philosophy with Pseudomonas organisms relates mainly to 
complete graft preservation; that does not necessarily con- 
traindicate subtotal excision and leaving a small cuff of graft 
in situ. 
When we excise the graft, we do send that material for 
culture, and generally speaking it has grown whatever 
organism has grown from the fluid. Except for altering 
antibiotic hoices, these results did not particularly change 
the management. 
And the last question is why do the late infections eem 
to do more poorly, and it is hard to know for sure. Certainly 
more of the grafts are occluded, but even with correcting 
for that, we found that the results were not as good as in 
the early group. It is not because the bacteriology is 
different, and it is not because there is more of a tendency 
toward anastomotic disruption. We are not stating that an 
attempt to preserve a graft should not be made with late 
infection in all cases, but we are recognizing that the success 
rate of 40% compared with 70% or 80% is certainly 
different and needs to be taken into account. 
Dr. Alan Dietzek (Great Neck, N.Y.). Do you use oral 
antibiotics after the discontinuation of intravenous antibi- 
otics, and if so, for how long? Also, what rate of reinfection 
or reoccurrence of infection have you seen with graft 
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preservation after the discontinuation of intravenous anti- 
biotics? 
Dr. Dougherty. We do not routinely use oral antibi- 
otics once a 6-week course of intravenous antibiotics has 
been used, but that they may have varied within the series. 
The recurrent infection rate is basically defined as what our 
results were. Again, in the late group, most wounds failed 
to heal. This did not relate to the cessation of antibiotics, 
as most failed while still on parenteral therapy. 
Dr. Bruce A. Perler (Baltimore, Md.). At Hopkins, 
out group has had an ongoing experience with the use of 
rotational muscle flaps in the treatment of infected pros- 
thetic bypass grafts. It is my sense that it is the extent of 
infection, and how it is treäted, that determine outcome 
much more than the time of presentation of the infection. 
Specifically, we häve had comparably good results with 
early as well as late infections. 
I also believe that there is a fundamental difference 
between a truly infected graft on the one hand and an 
exposed graft in an infected wound, which we tend to see 
early, on the other. This may be one explanation for your 
superior esults with "early" graft infection. 
You have mentioned muscle flaps a couple of times but 
have not reported specifically how often they were per- 
formed in your series. What is your experience with 
rotational muscle flaps in the treatment of graft infection, 
and why do you have such a pessimistic attitude with 
respect o this form of treatment? 
Dr. Dougherty. It is a little hard to be totally sure 
when you are dealing with a local wound problem versus 
a graft infection less than 30 days after operation, but we 
believed that by stringently requiring that there be pus, that 
is, white cells on the gram stain and bacteria in the culture, 
that this really should eliminate simple wound dehiscences 
and whatnot. But I agree with you that there may be some 
bias there, and I also would point out that because it is a 
relatively small sample group who actually presented late 
with patent grafts, the statistical significance in the differ- 
ence was only at the .03 level, so we can not condemn too 
strongly the attempts at salvaging late graft infections. 
With regard to muscle flaps; I would say that we use 
them in approximately 25% to 30% of patients, mainly at 
this time in patients with exposed rein grafts. Again, from 
our previous publication we had shown really no difference 
in cost, success, or a number ofother factors when looking 
at flaps versus no flaps. We are not necessarily against them; 
it is just that we are not sure that it adds that much in many 
of these patients. However, lately we have been using them 
more. 
Dr. Thomas F. Panetta (Brooldyn, N.Y.). Because 
you had recurrence of infection in patients not receiving 
antibiotics and ~ecause these grafts are chronically infected, 
do you think that long-term, not necessarily organism- 
specific oral, antibiotics may be an adjunctive therapy in 
these cases to suppress graft infections and prevent 
recurrences? 
I was a little concerned about the stratification. 
Certainly you had a bimodal distribution, but your 
organisms were similar for both groups. Did you look 
at your graft infections between 3 and 6 months, for 
example? How many ofthose were associated with wound 
infections that healed and then presented with graft 
infections, and was there a difference in stratification of 
bacteria, looking, for example, at the difference between 
graft infections from 0 to 6 months or from 0 to 9 
months? 
Dr. Dougherty. We have not routinely recommended 
long-term oral antibiotics, but I would say that a number 
of these pätients have been kept on antibiotics. The 
problem, of course, is that specific antibiotics for many of 
these organisms are not that easily administered in an oral 
route. Most patients who failed graft preservation did so 
before cessation of antibiotics. 
With regard to your second question, itgets a little hard 
to break down the culture results at various intervals, 
because the numbers of patients are small. Really, the only 
large group of patients is in that first month. And 
particularly when you are just looking at gram-negative 
versus gram-positive, I do not think we would be able to 
achieve any statistically viable conclusions ubgrouping it 
that way. 
Dr. Ascer (Brooldyn, N.Y.). Do you think that these 
improved results are mostly due to this management 
approäch or are because you are more aggressive about 
limb salvage once the graft closes and you do not give up, 
you just keep at it? What do you think is the most important 
factor for your improved results in relation to the rest of the 
literature? 
Dr. Dougherty. Regarding the amputation rates in 
these patients, I would say that it is the fact that we are 
trying to preserve these grafts. I think even if one tries to 
revascularize these limbs with total graft excision, you are 
looking at often fairly complex operations in patients with 
poor conduit. More than half of the patients who hemor- 
rhaged or who had ongoing sepsis had attempts at 
complete xcision and autologous closure, so I think we can 
directly attribute the improved limb salvage rates to the fact 
that we are preserving patent grafts. Also, many patients do 
not have any other outflow arteries available. 
Dr. Jesse A. Blumenthal (New York, N.Y.). In this 
large series was there any different correlation to patients 
who had ongoing sepsis in the extremity? And after 
reviewing this sm@, any advice on treating peripheral 
sepsis before or in relation to putting the grafts in? 
Dr. Dougherty. You are asking whether the patients 
had sepsis before operation? 
Dr. Blumenthal. That's right. Patients who come in 
for limb salvage and have cellulitis, etcetera, in the leg, how 
much greater isk do those patients have of evenmal graft 
infection? Have you had any correlation? 
Dr. Dougherty. Unfortunately, we could not look at 
the stare of the patients before their original bypass, many 
of which were performed at other institutions. Obviously, 
I think it is intuitive that patients presenting with a septic 
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foot are going to have a higher incidence ofinfections. The 
rast majority, if not all of these patients, had limb salvage 
indications in the first place, so I suspect that a significant 
number did have some degree of sepsis. 
Dr. Blumenthal. We presented a series several years 
ago in which patients requiring above-knee amputation, 
not infected, there was a tremendous increase in subsequent 
infection if the prosthetic graft was not completely 
removed at the time of the above-knee amputation. Did 
you find anything similar? 
Dr. Dougherty. We did not look at that, but we are 
aware of your results. 
Dr. Robert S. Walsky (Emerson, N.J.). I raise a little 
caution in accepting the concept of completely sterilizing 
an infected graft. One is a patient with an "infected" wound 
done from an umbilical rein bypass at a sister instimtion 
who eventually underwent muscle flap and a year later came 
in with a ruptured pseudoaneurysm from a "cleaned up" 
wound. 
Next is a lady who I just finished treating who in 1982 
underwent a fern-fern and in 1985 had a groin infection, 
had the graft removed with a little Dacron cuff left, it 
granulated in, and the monofilament sumre was completely 
granulated over. This year she now has a second sinus from 
that little Dacron cuff. Both patients were treated with 
obturator bypasses, but they give me the feeling that 
complete xcision is the ultimate treatment, and only under 
rare circumstances would I look for a big wound healing in 
over a foreign material. 
Dr. Dougherty. That has obviously been the feeling of 
most surgeons for a long time, but one has to also 
remember that what motivated this approach for out 
groups was that the results with total excision really were 
not very good, especially if you look at limb salvage. Total 
excision does not protect from anastomotic rupmre or vein 
patch rupture. In many of these patients who have had 
multiple operations, you are going to be putting a 
prosthetic in, and new prosthetics certainly can ger infected 
as weil I do not tbink that we have long enough follow-up 
to give you an answer as to what the ultimate recurrence of 
infection rate is going to be. We do have about a 3-year 
median follow-up in the patients o far, and the results are 
as presented. 
Dr. Frank J. Veith (New York, N.Y.). Our longest 
follow-up was more than 20 years, so some of these grafts 
that are left in infected fields do heal and stay healed. 
Dr. Alec N. Simpson (South Plainfield, NJ.). We had 
looked at out graft infection group several years back, and 
two of the patients were immunosuppressed patients. Late 
in the course of their graft development, infection devel- 
oped. One was on steroids for rheumatoid arthritis, and the 
other was a polycythemic. I am wondering to what degree 
some of your late graft infections are immunosuppressed? 
Some of them are subfly immunosuppressed and might be 
one of the causes they do not do so well as far as graft 
preservation goes. 
Dr. Dougherty. That is an interesting thought. 
Obviously it may be that all late graft infections are acmally 
smoldering early graft infections that do not present until 
later, and perhaps the fact that they present later suggests 
that the patients are not as immunologicaUy intact. Really, 
all we could draw in conclusions from our series is that the 
late grafts did not do as weil, and the reason for that is not 
clear. 
Dr. John J. Ricotta (Buffalo, N.Y.) I am not sure that 
I understood your previous answer. What was the mecha- 
nism of failure in the late graft group where you tried 
preservation? In other words, I understand there was a 
difference, and I understand all the things that you looked 
at seemed to be the same, but have you looked at the grafts 
that failed and gotten any sense of why they failed? 
The second thing I'd like you to emphasize ishow you 
would deal with an occluded graft and exactly what subtotal 
excision is. We have had some bad luck when we do 
anything less than a near total excision, in other words, 
leaving the cuff. But if we leave any part of a clotted graft 
in, it is a big problem. And I have a feeling that you are 
doing a near total excision, and I think it is going to be 
important to emphasize. 
Dr. Dougherty. Regarding your first quesuon, the 
causes of late failure obviously included those patients 
who had systemic sepsis or bleeding, but it also included 
in the larger part patients who simply did not heal their 
wounds, who failed to granulate over the graft, and who 
ultimately had to be managed by at least a partial graft 
excision. 
What do we mean by subtotal excision? We excise all of 
the occluded graft other than the very smallest cuff that we 
can satisfactorily close, and that bit of cuff is going to be 
completely in contact with the flowing blood in the 
underlying artery. We feel that this is less likely to blow out 
than autologous patch closure. 
